Breast Cancer Trial, Recruiting NCT07557654 Sponsor: Fudan University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07557654
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Female patients who have had a chest CT scan done without contrast dye
  • People who have also had at least one other breast imaging test, such as a mammogram and/or a breast MRI
  • If a breast lump or abnormality was found, it must have been confirmed through a tissue sample (biopsy) or by being monitored by a doctor for at least 12 months
  • People who had not received any cancer treatment — either to the whole body or a specific area — before their imaging scans were taken
  • People whose scan images are complete and clear enough to be used in the study

Who may not be able to join:

  • People who have a history of another type of cancer that could affect how breast scans are interpreted
  • People who have a suspected breast abnormality that has not been confirmed by a tissue sample or medical follow-up
  • People who received radiation therapy, chemotherapy, or immunotherapy before their imaging scans were taken
  • People whose scan images are incomplete, poor quality, or have technical problems that make them difficult to analyse reliably
  • People whose chest CT scan and other breast imaging tests were done more than three months apart, or where a significant health event happened between the two scans that may have changed the status of any breast abnormality (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yajia Gu, MD, Fudan University

Phone: +86-021-15800780035

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 May 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Screening performance of non-contrast chest CT for detection of breast cancer, with comparison to mammography and/or breast MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov